UGT2B7
MOLECULAR TARGETUDP glucuronosyltransferase family 2 member B7
UGT2B7 (UDP glucuronosyltransferase family 2 member B7) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting UGT2B7
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of | 2.20 | 8 |
| 2 | celastrol | 0.69 | 1 |
About UGT2B7 as a Drug Target
UGT2B7 (UDP glucuronosyltransferase family 2 member B7) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented UGT2B7 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
UGT2B7 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.